Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe updated page uses a revised layout while preserving core study details (title, conditions, interventions, criteria, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check16 days agoChange DetectedAdded related topics sections for 'Multiple myeloma' and 'MedlinePlus Genetics' on the Study Details page.SummaryDifference0.2%

- Check24 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma; genetics content on that disease is no longer shown on the page.SummaryDifference0.3%

- Check38 days agoChange DetectedUpdate to v3.2.0 with an added MedlinePlus Genetics topic (Multiple myeloma) and a government operating status notice; old v3.1.0 was removed.SummaryDifference5%

- Check45 days agoChange DetectedTerminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and version bumped from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check52 days agoChange Detected- Removed MedlinePlus Genetics topic on multiple myeloma. - This reduces the page's coverage of a genetics-related disease topic.SummaryDifference0.4%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.